About this trial
This is a single-blind, single-center, parallel-group randomized controlled trial with the following objectives: First, researchers aim to compare the clinical efficacy of 2mm and 2.5mm post-limbal needle insertion in YAMANE technique for patients with congenital ectopia lentis. Second, the goal is to investigate the mean absolute refractive prediction error, IOL tilt and decentration, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and corneal endothelial cell count at 3 months postoperatively. Third, it intends to explore the incidence of postoperative complications of the two needle insertion positions in this specific surgical method. Finally, this study aims to provide evidence for ophthalmic clinical practice, explore the optimal needle insertion point, and offer more precise and safe surgical plans for patients requiring sutureless transscleral IOL fixation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 4-18 years (regardless of gender) who meet the indications for YAMANE technique.
Patients who can complete a follow-up period of at least 3 months after surgery.
Patients or their legal guardians who provide informed consent to participate in this study.
Disqualifiers
Patients with concurent secondary qlaucoma, retinal detachment, strabismus, or other relevant ocular complications (excluding refractive errors).
Patients participating in other trials that may affect the results of this study.
Trial design
Parallel
Treatments tested in this trial
YAMANE technique(Suture Needle Insertion at 2.5 mm Posterior to the Limbus)
Procedure/SurgeryParticipants in the intervention group should complete a comprehensive ophthalmic examination at baseline, undergo needle insertion 2.5mm post-limbal during surgery, and receive routine follow-up at 1 week, 1 month, and 3 months postoperatively.
Treatment groups
Trial outcomes
Primary outcomes
Refractive Predictive Error of Patients at the 3-month Postoperative Follow-up
Case report form records
Secondary outcomes
Uncorrected Visual Acuity (UCVA) of Patients at the 3-Month Postoperative Follow-up
Measured using the EDTRS chart
Best-Corrected Visual Acuity (BCVA) of Patients at the 3-Month Postoperative Follow-up
Measured using the EDTRS chart
IOL Tilt in Patients at the 3-Month Postoperative Follow-up
by the Casia 2 AS-OCT Instrument
IOL Decentration in Patients at the 3-Month Postoperative Follow-up
by the Casia 2 AS-OCT Instrument
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: